BioCatch vs Post Quantum

BioCatch has a disclosed valuation of $1B, while Post Quantum's valuation is not publicly available, making a direct size comparison difficult. BioCatch employs 100-500 people.

BioCatch has raised more in total funding at $213M, compared to Post Quantum's $30M — a gap of $183M.

BioCatch holds the higher Awaira Score at 80/100, compared to Post Quantum's 45/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 35-point gap that reflects meaningful differences in scale or traction.

BioCatch was founded by Avi Turgeman in 2011. Post Quantum was founded by Andersen Cheng in 2009. Visit each company's profile on Awaira for a full founder biography.

BioCatch: BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud.\n\nThe company raised approximately $213 million in venture funding including a Series D led by Tiger Global, reaching a valuation exceeding $1 billion. BioCatch counts over 30 tier-one banks globally among its clients including American Express, NatWest, and Lloyds Banking Group, with deployments protecting online banking and mobile banking sessions from fraud that bypasses traditional authentication controls. The platform is particularly effective against malware-assisted fraud and social engineering scams where the genuine account holder is unknowingly manipulated.\n\nBioCatch competes in the behavioural biometrics and fraud intelligence market alongside ThreatMetrix (now LexisNexis Risk Solutions), Sift, and Sardine, as well as traditional fraud management platforms from FICO and SAS. Its differentiation is the depth of its behavioural feature engineering from passive interaction signals that do not require active user participation, creating a fraud layer that operates continuously without adding friction to legitimate user journeys. The growing prevalence of authorised push payment fraud and social engineering attacks in European banking has expanded the relevant use case for BioCatch beyond traditional account takeover detection. Post Quantum: Post Quantum develops cryptographic security products designed to withstand attacks from quantum computers, offering post-quantum encryption protocols, secure communications applications, and identity verification technology that protect data against both classical and quantum computing threats. The London company is among the longest-established organisations in the quantum-safe cryptography market, having focused on this security category before it gained mainstream attention following NIST post-quantum cryptography standardisation efforts.\n\nThe company raised approximately $30 million in venture funding and counts government agencies, financial institutions, and critical infrastructure operators among its clients. Post Quantum products include an encrypted communications app and a software library implementing post-quantum cryptographic primitives, as well as consulting services for organisations planning cryptographic migrations. The company has participated in NATO and government procurement processes for quantum-safe communications.\n\nPost Quantum competes with Quantinuum, IBM Quantum Safe, and PQShield in the post-quantum cryptography market, as well as larger cybersecurity vendors integrating quantum-safe features into existing product suites. The NIST finalisation of post-quantum cryptography standards in 2024 significantly accelerated enterprise and government planning for cryptographic migration, expanding the commercial opportunity for specialist vendors. The harvest now decrypt later threat model, where adversaries collect encrypted data today to decrypt once quantum computers mature, is creating compliance urgency in defence, financial services, and national security organisations.

Post Quantum was founded first in 2009, giving it 2 years of additional market experience. BioCatch was founded later in 2011. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.

BioCatch has approximately 100-500 employees, while Post Quantum has approximately 1-50. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.

Yes, BioCatch and Post Quantum are direct competitors — both operate in the AI Security space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.